recent post

IASST Guwahati researchers discover treatment for Type I and Autoimmune Diabetes Mellitus

November 6, 2024
recent post

FICCI HEAL 2024 stresses on AI for better health

recent post

Venus Remedies bags Malaysian PIC/S GMP approval for pre-filled syringe facility

recent post

Apollo Clinic secures NABH certification for its clinics in Karnataka

November 5, 2024
recent post

Dr Sandeep Nilkanth Athalye joins Kashiv BioSciences as Global CEO

Parexel ropes in Mike D’Ambrosio as Senior Vice President, Global Head, Real World Research

Parexel ropes in Mike D’Ambrosio as Senior Vice President, Global Head, Real World Research

D’Ambrosio will lead strategic initiatives to enhance customer engagement and delivery across Real World Data (RWD) and RWE services

Parexel has appointed Mike D’Ambrosio as Senior Vice President, Global Head, Real World Research. In this role, D’Ambrosio will lead strategic initiatives to enhance customer engagement and delivery across Real World Data (RWD) and RWE services, helping to foster a deeper understanding of patient experiences and outcomes to ensure safety and efficacy in the drug development process.

“With the increasing complexity of asset development and the variability of stakeholder evidentiary needs across lifecycle management, the importance of RWD/RWE strategies has become a critical need. Generation of high-quality RWE across primary, secondary and hybrid data collection methodologies can accelerate and de-risk asset development, differentiate medicines in the real-world setting and drive value creation across lifecycle management — ensuring new medicines can be brought to patient communities safely and effectively,” shared D’Ambrosio.

D’Ambrosio served as Vice President, Head of Real World Evidence Solutions, at Syneos Health, where he held various roles of increasing responsibility in operations, consulting and leadership over his eight-and-a-half-year tenure with the company. Most recently, he led the RWE solutions consultancy group, overseeing the strategy and delivery of real-world evidence, health economics and outcomes research, epidemiology and data sciences consulting.

D’Ambrosio was also a member of the Medical Affairs leadership team, playing a pivotal role in enhancing functional capabilities, spearheading thought leadership in RWE and championing the wider adoption of RWE across the entire product development journey. He has significant experience developing and implementing growth strategies and driving go-to-market differentiation. While at Syneos Health, D’Ambrosio led several high-profile business initiatives securing preferred provider partnerships as part of the organization’s Real World Data strategy in Europe.